Brief: NextCell Pharma Q1 Operating Income Rises To SEK 3.0 Mln
26/01/2023 06:33
Jan 26 (Reuters) - NextCell Pharma AB NXTCL.ST :
* Q1 OPERATING INCOME AMOUNTED TO 3 012 (1 347) TSEK
* Q1 OPERATING RESULT AMOUNTED TO -8 918 (-6 472) TSEK
Source text for Eikon: ID:nWkr9XQNpP
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln